KLEIN JOSEPH III
SEC Form 4 insider trading activity
KLEIN JOSEPH III has filed 7 SEC Form 4 filings (27 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Jul 6, 2026.
On the most recent filing, KLEIN JOSEPH III is listed as Director at IONIS PHARMACEUTICALS INC. Inside the rolling window, KLEIN JOSEPH III reported no open-market purchases and 5 open-market sales totaling $5.4M in IONS. The largest disclosed transaction in the window is a sale of 21,332 IONS shares on Mar 3, 2026, worth $1.7M.
Companies traded
Other insiders at IONS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 3, 2025 | IONS | Sale | $1.7M |
Frequently asked questions
How many SEC Form 4 filings has KLEIN JOSEPH III made?
KLEIN JOSEPH III has filed 7 SEC Form 4 filings (27 transaction rows) across 1 company since 2025.
Which companies does KLEIN JOSEPH III trade?
KLEIN JOSEPH III has filed SEC Form 4 disclosures for 1 company, including IONS.
When was KLEIN JOSEPH III's most recent SEC Form 4 filing?
KLEIN JOSEPH III's most recent SEC Form 4 filing on Tracefour is dated Jul 6, 2026.
What is KLEIN JOSEPH III's total buy and sell value in the current window?
Inside the rolling retention window, KLEIN JOSEPH III bought $0 and sold $5.4M based on SEC Form 4 filings.
What was KLEIN JOSEPH III's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 21,332 IONS shares on 2026-03-03, worth $1.7M, per SEC Form 4 filings.